Immunovant GAAP EPS of -$0.61 beats by $0.10
Source: SeekingAlpha
2026-02-06 07:03:08 ET
More on Immunovant
- Immunovant: 'Buy' On Competitive Batoclimab Landscape And IMVT-1402 Advancement
- Immunovant, Inc. (IMVT) Q2 2025 Earnings Call Transcript
- Immunovant drops 7%, prices $550M stock offering
- Seeking Alpha’s Quant Rating on Immunovant
- Historical earnings data for Immunovant
Read the full article on Seeking Alpha
For further details see:
Immunovant GAAP EPS of -$0.61 beats by $0.10
Immunovant Inc.
NASDAQ: IMVT
IMVT Trading
-1.76% G/L:
$25.425 Last:
615,902 Volume:
$26.43 Open:
IMVT Latest News
February 06, 2026 07:00:00 am
Immunovant Provides Corporate Updates and Reports Financial Results for the Third Quarter Ended December 31, 2025
IMVT Stock Data
$5,418,026,632
84,872,919
0.1%
62
N/A
Biotechnology & Life Sciences
Healthcare
US
New York
